Nathan H. Boyd

Nathan Boyd practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Nathan Boyd's NPI, 1528387792, was assigned on May 26, 2010. Nathan Boyd graduated from The University of New Mexico School of Medicine in 2006. Nathan Boyd holds New Mexico license MD2012-0168.

Nathan Boyd's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Nathan Boyd's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc.

Dmand AI tracks the electronic health record (EHR) system at each site where Nathan Boyd practices. Vendor and product names are available with a free account.

Otolaryngology/facial plastic surgery is Nathan Boyd's primary specialty in the NPI Registry, under taxonomy code 207YX0905X. Nathan Boyd is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Nathan Boyd's licenses on file in 3 states: New Mexico, California and Iowa.

Dmand AI lists ear infection, larynx and vocal cord disease and thyroid surgery among the conditions Nathan Boyd treats.

CMS data shows 75 Medicare services from Nathan Boyd across 4 procedure codes in 2024, for 82 Medicare patients. Medicare paid $12,331 for them.

CMS counts 82 Medicare patients who saw Nathan Boyd in 2024. The largest group is 65 to 74, with 53 patients. 65% of them have high cholesterol, and 61% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nathan Boyd's median patient age at 70, with 67% women.

In 2024, Nathan Boyd wrote 41 Medicare Part D claims for 16 patients. 98% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $1,122 in total drug cost. In 2019, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Nathan Boyd for performance year 2024, reported as part of a group. Nathan Boyd accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nathan Boyd as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 25 papers to Nathan Boyd, published from 2011 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Carcinoma, Squamous Cell, Neck Dissection and Postoperative Complications. Nathan Boyd has published most often in Ann Otol Rhinol Laryngol. Nathan Boyd's most frequent co-authors are Garth T. Olson, MD, Antoinette Rosa Esce, MD and Shweta Agarwal, MD.

CMS Open Payments shows 4 general payments to Nathan Boyd from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. LivaNova PLC paid the most, $104.

Nathan Boyd graduated from The University of New Mexico School of Medicine in 2006. Nathan Boyd is a member of NHS.

Nathan Boyd is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.